Clinical Trial Update: Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of nifuroxazide for hepatic encephalopathy in patients with liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Nifuroxazide (nifuroxazide)

Snippet

Sponsor: Cairo University | Conditions: Hepatic Encephalopathy | Phase 3 | Status: COMPLETED